| March
25 , 2010 (No CME
awarded for this meeting)
OC
Airport Double Tree Hotel
201 East MacArthur Blvd.
Santa Ana, CA 92707
Network
and Welcome Reception: 6:30 pm
Dinner & Speaker:
7:45 pm
Speaker: |
Joel Teichman, M.D., FRCSC, Associate Professor
of Surgery/Urology at the University British Columbia
and Head of the Division of Urology for Providers
Healthcare, Vancouver, BC, Canada |
| Topics: |
“Update on Interstitial Cystitis Therapy” |
At
the conclusion of this activity, the participant
will be able to:
1)
Discuss the current updates in Interstitial Cystitis.
2) Appraise the most important factors of the changes
in IC therapy.
3) Assess how the changes will impact physician's
practices. |
TOTAL
ATTENDEES: 31
Stephen
M. Auerbach, MD
Bill Bonney, MD
Jill G. Byers, MD
Atreya Dash, MD
Lamia Gabal-Shehab, MD
Jeffrey E. Kaufman, MD
Fred Khonsari, MD
Huey Lin, MD
Michael K. Louie, MD
August J. Maggio, MD
Anthony Reddy, MD
Eric Robins, MD
Alfred A. Sidhom, MD
Karan J. Singh, MD
Nhiep Tang, MD
Joel M.H. Teichman, MD
Thomas Vandergast, MD
TOTAL: 17
SUPPORTERS
Kimi Atchason - Bayer
Chris Casey - Bayer
Rita Gayman - AstraTech
Michelle Lynch - Abbott
Gloria Martinez - Auxilium
David Meteyer - University Specialty Urologicals University
Compounding Pharmacy
Shannon Nielsen - Astellas
Rich Proctor - Bayer
Romeo Ramos - Novartis Pharma Corp.
Gloria Rodriguez - Slate
Harpreet Sheridan - Astellas
Jenny Yan - Novartis
TOTAL: 12
DIRECTORS
Jeannie DeSantis
Kathy DeSantis
|
|
